Terapia con células madre para la alopecia, perdida de cabello.

Los investigadores han descubierto una nueva forma de activar y aumentar la cantidad y calidad de las células madre en los folículos pilosos para hacer crecer el cabello..

Ayudará al crecimiento del cabello en personas con calvicie o alopecia., which is hair loss associated with such factors as hormonal imbalance, estrés, aging or chemotherapy treatment.

Hair follicle stem cells are long-lived cells in the hair follicle; they are present in the skin and produce hair throughout a person’s lifetime. They are «quiescent,» meaning they are normally inactive, but they quickly activate during a new hair cycle, which is when new hair growth occurs. The quiescence of hair follicle stem cells is regulated by many factors. In certain cases they fail to activate, which is what causes hair loss.

Adding more stem cells by using local injections would activate the cells and grow hair more quickly.

Stimulation of hair growth through hair follicle stem cells is very promising given how many millions of people, both men and women, deal with hair loss. I

When talking about hair transplant therapies, Terapia con células madre is one such process considered for hair loss. This treatment is very efficient. It is a non-surgical therapy to stimulate and regrow hair follicles. Stem cells that are present in the middle of the follicle ensure the continuous supply of cells.

Procedimiento (sample) :

Human stem cells therapy protocol and injections.
For each patient, the scalp affected by hair loss was divided into four areas (frontal, parietal, vertex, and occipital); local anesthesia was injected in the treated areas. Interfollicular SCs injections (0.2 mL·cm2) were administered to select areas of the scalp at a depth of 5 mm.

In patients with hair loss localized to the frontal and parietal regions, SCs injections were delivered exclusively to the frontal scalp

For patients with hair loss limited to the parietal and vertex regions, HSCs was injected in the parietal region

Patient (sample):

A smoker 45-year-old male patient affected by androgenetic alopecia classified AGA 3 according to Nordwood-Hamilton scale.

Clinical results
In total, 23 weeks after the last treatment with HSCs mean hair count and hair density increases over baseline values . En particular, a 29%±5% increase in hair density for the treated area .

In this preliminary report, we showed the clinical effect of the injections of stem cells into the scalp tissue.

Stem cells can improve the formation of new follicles.

Detalles – https://nbscience.com/nbs-stem-cells-clinic/